Philip Morris said it expects to record a loss on the sale of its inhaled-therapeutics unit to Molex Asia Holdings as it ...

Have you seen pharmaceutical products being offered for sale in unusual circumstances? “We’d like to remind people to only ...

Bausch + Lomb is assessing interest from potential buyers as a way around the roadblock, the FT wrote. The company had a market cap of $6.27 billion on Monday.

The Federal Trade Commission announced today it has settled a lawsuit against drug company Cephalon, now owned by Teva Pharmaceutical Industries, for $1.2 billion – the largest settlement of its ...

The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 75,409 shares of Amphastar Pharmaceuticals Inc. Warning! GuruFocus has detected 3 Warning Signs ...

WASHINGTON - 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW), a biopharmaceutical company specializing in the development of treatments for infectious diseases, disclosed the sale of shares and ...

TOKYO -- Japan's Mitsubishi Chemical Group has taken steps toward selling subsidiary Mitsubishi Tanabe Pharma, rethinking its position in the R&D-intensive pharmaceutical sector to free up funds ...

A French pharmaceutical company has been trying to stop a proposed condo development near its Toronto campus by arguing that the nearby residential towers will present a security risk to its ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

The single-center open-label relative bioavailability and dose proportionality study enrolled 30 healthy adult volunteers and compared the pharmacokinetic profile of AD04 when administered as an oral ...